All conditions

Gastro-oesophageal Reflux Disease

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

1137
Trials on record
105
Recruiting now
1
Australian sites
3
Phase 3 trials
5
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Gastro-oesophageal Reflux Disease →

Get alerts when Gastro-oesophageal Reflux Disease trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Gastro-oesophageal Reflux Disease (GORD)

Gastro-oesophageal reflux disease, commonly known as GORD, is a condition where stomach acid regularly flows back up into the oesophagus — the tube that connects your mouth to your stomach. Normally, a small muscle at the bottom of the oesophagus acts like a valve, keeping stomach contents where they belong. In people with GORD, this valve does not work as well as it should, allowing acid to escape upward. This can cause symptoms like heartburn, a burning feeling in the chest or throat, regurgitation of food or liquid, difficulty swallowing, and sometimes a persistent cough or sore throat.

GORD is quite common in Australia, affecting an estimated one in five Australians to some degree. It can occur at any age, including in babies and children, though it tends to be more frequently diagnosed in adults. Certain factors can make GORD more likely, including being overweight, smoking, pregnancy, and eating particular foods or drinks. Having GORD does not mean something is seriously wrong with you, but it is worth managing because regular acid exposure can irritate the lining of the oesophagus over time.

Treatment for GORD generally focuses on reducing the amount of acid the stomach produces and making lifestyle changes that can ease symptoms. Doctors commonly discuss options such as medications that lower acid levels, dietary adjustments, changes to eating habits and timing of meals, and weight management where relevant. In some cases where symptoms are persistent or more complex, further investigations or other approaches may be considered. A GP or specialist is the right person to talk through which options suit your individual situation.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Gastro-oesophageal Reflux Disease in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for Gastro-oesophageal Reflux Disease

5 medicines listed on the PBS for Gastro-oesophageal Reflux Disease. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 5 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
Esomeprazole Noxicid Caps, Esomeprazole RBX Gastro-oesophageal reflux disease AU$4 Authority required
Lansoprazole Zopral, Zoton FasTabs Gastro-oesophageal reflux disease AU$3.42 Streamlined authority
Omeprazole OMEPRAZOLE CAPS WGR, Maxor EC Tabs, Losec Tablets Gastro-oesophageal reflux disease AU$3.5 Streamlined authority
Pantoprazole Somac Gastro-oesophageal reflux disease AU$2.5 Streamlined authority
Rabeprazole Rabeprazole Sandoz Gastro-oesophageal reflux disease AU$3.33 Streamlined authority
Esomeprazole Noxicid Caps, Esomeprazole RBX gastro-oesophageal reflux disease (GORD) Complex AU$4 Authority required
Lansoprazole Zoton FasTabs, Zopral gastro-oesophageal reflux disease (GORD) Complex AU$4 Authority required
Omeprazole Losec Tablets, Maxor EC Tabs, OMEPRAZOLE CAPS WGR gastro-oesophageal reflux disease (GORD) Complex AU$4 Authority required
Pantoprazole Somac gastro-oesophageal reflux disease (GORD) Complex AU$2.87 Authority required
Rabeprazole Rabeprazole Sandoz gastro-oesophageal reflux disease (GORD) Complex AU$3.33 Authority required

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for Gastro-oesophageal Reflux Disease currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Gastro-oesophageal Reflux Disease.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Gastro-oesophageal Reflux Disease by country. Australia is highlighted.

Showing the top 10 of 38 countries with trial sites.

Clinical trials for Gastro-oesophageal Reflux Disease

Showing 105 of 105 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT06839248 · St Vincent's Hospital Melbourne Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇦🇺 AU

Who might be able to join this trial: - People who are 18 years of age or older at the time of joining the trial. - People who have been regularly taking any type of once-weekly GLP-1 medication (a type of injection used for diabetes or weight management) for at least one month before the trial begins. - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00260585 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2050
🇺🇸 US

Who might be able to join this trial: - You have a known or suspected cancer in the food pipe (esophagus) or where the food pipe meets the stomach - You have been diagnosed with a condition called Barrett's metaplasia, where cells in the food pipe change in an abnormal way - You are being treated for symptoms of acid r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00574327 · Midwest Biomedical Research Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - You must be a patient eligible for care at the Kansas City VA Hospital, where this study is taking place. - You have been diagnosed with Barrett's esophagus (a condition affecting the lining of the food pipe), with or without abnormal cell changes, or you have acid reflux dis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03418350 · National Jewish Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with IPF (idiopathic pulmonary fibrosis, a lung condition causing scarring) - People aged between 40 and 95 years old - People who are able to read, speak, and understand English - People who take medication for acid reflux or GERD (gastroesophageal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03596476 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 May 2027
🇫🇷 FR

Who might be able to join this trial: - People who are older than 18 years of age - People who experience typical acid reflux symptoms (such as heartburn or stomach contents coming back up into the throat) at least twice a week, even while taking acid-reducing medication called a PPI for at least one month - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03669874 · IRCCS San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 16 September 2021
🇮🇹 IT

**Who might be able to join this trial:** - People who have had symptoms of acid reflux (GERD) — either in the oesophagus (such as heartburn) or in other areas like the throat or lungs — for more than 6 months - People who have had a test (endoscopy or pH-impedance study) confirming acid reflux or related oesophageal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03886961 · University of Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 March 2027
🇺🇸 US

Who might be able to join this trial: - People who have had a lung transplant (single lung, double lung, or a repeat transplant) and whose lung function has been stable across their last two medical visits - People who had signs of acid reflux, abnormal swallowing test results, or stomach acid problems identified befor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03961945 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2030
🇺🇸 US

**Who might be able to join this trial:** **Group 1 (Aim 1 – people being screened for Barrett's Esophagus):** - Adults between the ages of 50 and 85 - People who have three or more known risk factors for a condition called Barrett's Esophagus - People who have been diagnosed with acid reflux disease, OR have taken ce...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04255693 · Federal State Budgetary Scientific Institution Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇷🇺 RU

**Who might be able to join this trial:** - People who are willing to take part and have signed a consent form agreeing to participate - People who have been diagnosed with gastroesophageal reflux disease (acid reflux), shown by at least weekly heartburn and/or regurgitation that has been ongoing for at least 3 months...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04358146 · United Pharmaceuticals Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 3 December 2026
🇧🇪 BE🇫🇷 FR🇬🇷 GR🇮🇹 IT

**Who might be able to join this trial:** - Infants who have had at least 2 regurgitation (spitting up) episodes per day over the past 2 weeks, and at least 4 regurgitation episodes per day on average over the last 2 days - Infants who are fed exclusively or mostly with formula (not breastfed, or mostly formula-fed) -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04383262 · Medical College of Wisconsin Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have been clinically diagnosed with laryngopharyngeal reflux (LPR), which is a condition where stomach acid travels up to the throat - People who are 18 years of age or older (but under 65) - People whose symptom scores on two specific reflux questionnaires (calle...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04411823 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People with a Body Mass Index (BMI) of 30 or higher (a measure of body weight relative to height that indicates obesity) - People who are able to give their own informed consent to take part in the procedure - People who do not have a stomach ulcer...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04422405 · Spital Limmattal Schlieren Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 May 2035
🇨🇭 CH

**Who might be able to join this trial:** - People with a Body Mass Index (BMI) over 35 kg/m² (a measure of body weight relative to height that indicates severe obesity) - People who have been following a medically supervised obesity treatment program for at least 2 years without significant weight loss - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04901429 · Baylor Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older who have been assessed as suitable for revision weight loss surgery that converts a sleeve gastrectomy to a gastric bypass. - People who are already scheduled to undergo this type of revision weight loss surgery. Who may not be able to join: - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04930029 · University Hospital, Lille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who had a specific type of weight-loss surgery called OAGB (a form of gastric bypass) 10 years ago, roughly between 2009 and 2013, where a particular section of the intestine (either 150cm or 200cm) was used during the procedure - People who met the standard medical g...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04945304 · Unidad Internacional de Cirugia Bariatrica y Metabolica Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
Venezuela

Who might be able to join this trial: - People who are older than 18 years of age - People who have been considered as a candidate for weight-loss (bariatric) surgery - People who have obesity - People with a Body Mass Index (BMI) greater than 30 kg/m²(a number calculated from height and weight that doctors use to meas...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04994665 · Centre Hospitalier Departemental Vendee Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older. - People who are scheduled to have a sleeve gastrectomy (a type of weight-loss stomach surgery) as their first weight-loss operation. - People with a Body Mass Index (BMI) of 35–40 who also have at least one serious health condition that surgery is l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05066594 · IRCCS San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇮🇹 IT

Who might be able to join this trial: - People who have been assessed by a doctor as needing a specific non-surgical procedure (called TIF, using a device called EsophyX) to treat long-term acid reflux disease. - People who are able to attend follow-up appointments at San Raffaele Hospital over a 5-year period after th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05080634 · Maria Sklodowska-Curie National Research Institute of Oncology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2024
🇵🇱 PL

Who might be able to join this trial: - People aged 18 or older, of any gender, who are willing to sign a consent form agreeing to take part in the study - People who have been diagnosed with achalasia (a condition affecting the ability to swallow) and have already had a procedure called POEM (a minimally invasive surg...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05132816 · Prof Urs Zingg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇭 CH

**Who might be able to join this trial:** - People who are older than 18 years of age - People diagnosed with a specific swallowing muscle disorder of the food pipe called "ineffective esophageal motility," identified using a standardised measurement system — this means that during a swallowing test, either 7 out of 10...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05180253 · University of Louisville Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 85 years old - People who have never had surgery before - People who have no symptoms related to the stomach or food pipe (esophagus), based on standard questionnaires - People who are not currently taking any medications that affect stomach acid or the movement...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05320796 · Prof Urs Zingg Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇨🇭 CH

**Who might be able to join this trial:** - People who had a specific type of weight-loss stomach surgery (called Roux-en-Y gastric bypass, using a particular stapling method) at least 12 months before the study - People who took acid-reducing medication (called a proton pump inhibitor) routinely for 6 months after th...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05330910 · Sengkang General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇸🇬 SG

Who might be able to join this trial: - People between 21 and 65 years old - People who are able and willing to give their formal agreement to take part in the study - People whose pre-surgery camera examination of the throat and stomach showed a specific finding called "Hill's grade III" at the junction between the fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05455359 · Boston Children's Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 May 2027
🇺🇸 US

Who might be able to join this trial: - People between 5 and 21 years of age - People who receive more than 90% of their calories through a feeding tube and do not eat or drink by mouth - People who have been identified as being at high risk of aspiration pneumonia (where food or liquid enters the airway), based on a s...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05465629 · Viome Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who currently live in the United States - People aged between 25 and 75 years old (including those ages) - People who can speak and read English - People who have not experienced unexplained weight loss, fevers, anaemia, or blood in their stool - People who are willing and...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05469854 · Cinclus Pharma Holding AB Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 November 2026
🇸🇪 SE

Who might be able to join this trial: - People who are willing and able to give written consent to participate in the study. - Healthy men or women between 18 and 65 years of age. - People with a body mass index (BMI) between 18.5 and 35.0. - People and their partners who agree to follow the study's contraception requi...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05496998 · Medtronic Cardiovascular Not Applicable · 8 countries Recruiting
Recruiting Not Applicable Est. completion 1 August 2029
🇩🇰 DK🇫🇷 FR🇩🇪 DE🇮🇹 IT🇳🇱 NL🇪🇸 ES🇨🇭 CH🇬🇧 GB

**Who might be able to join this trial:** - You have a moderate-to-severe or severe leaky mitral heart valve (called mitral regurgitation) that is causing symptoms, OR you have a moderately leaky mitral valve combined with a narrowed mitral valve, along with calcium buildup around the valve - A specialist heart team a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05570448 · Midwest Veterans' Biomedical Research Foundation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have had ongoing acid reflux symptoms — such as heartburn or regurgitation — at least twice a week for the past 6 months - People who have had a special acidity test (called an ambulatory pH study) that has confirmed acid reflux is occurring **Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05696184 · Medical College of Wisconsin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 12 October 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 85 years old - People diagnosed with gastroesophageal reflux disease (GERD — a condition where stomach acid flows back into the food pipe) who experience regurgitation (stomach contents coming back up) and symptoms in the throat or airways, such as burning...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05697393 · Medical College of Wisconsin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇺🇸 US

Who might be able to join this trial: - The person must be 18 years of age or older. - The person has been diagnosed with gastroesophageal reflux disease (GERD), which is a condition where stomach acid flows back up into the throat or food pipe. - The person experiences symptoms such as ear, nose, or throat problems, a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05704348 · Helse Forde Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇳🇴 NO

Who might be able to join this trial: - People who are scheduled to have a type of weight-loss surgery called a laparoscopic sleeve gastrectomy (where part of the stomach is removed to reduce its size) Who may not be able to join: - People under 18 years of age - People who are using anti-reflux medication for reasons...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05777512 · Boston Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - Babies born before 32 weeks of pregnancy, assessed between 34 and 44 weeks of corrected age (counting from the original due date) - Babies who have been on a breathing machine (either through a tube in the airway, or through a mask or nasal prongs) for at least 48 hours at t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05781347 · Military University Hospital, Prague Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇨🇿 CZ

**Who might be able to join this trial:** - People who have been diagnosed with gastroesophageal reflux disease (GERD) — a condition where stomach acid flows back into the food pipe — and still have symptoms despite taking acid-reducing medications called PPIs, want to stop taking PPIs, or cannot tolerate them - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05870163 · Implantica CE Reflux Ltd. Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇩🇪 DE🇮🇹 IT🇳🇴 NO🇨🇭 CH

Who might be able to join this trial: - People who are willing and able to give informed consent and take part in the study. - People who are 18 years of age or older (or the legal age of adulthood in their country, if that is older than 18). - People who have had documented gastroesophageal reflux disease (acid reflux...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05899842 · Centre Hospitalier Universitaire de Nīmes Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇫🇷 FR

Who might be able to join this trial: - People who have been recommended to have a procedure called POEM (an internal muscle-cutting procedure done through an endoscope) for a swallowing condition called achalasia. - People with any type of achalasia whose symptoms score above 3 on a standard symptom scale called the E...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05974722 · David Krpata Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are willing and able to give informed consent to participate - People who are willing and able to attend follow-up visits and complete surveys over a longer period of time - People who have a Type II, III, or IV hiatal hernia l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05976165 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2027
🇺🇸 US

Who might be able to join this trial: - People whose main symptoms are heartburn or acid coming back up into the throat (gastroesophageal reflux disease symptoms) - People who are able to understand and sign a consent form agreeing to take part in the trial Who may not be able to join: - People who have previously bee...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05989698 · Cough Monitoring Medical Solutions Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇵🇹 PT

Who might be able to join this trial: - People who are 2 years of age or older. - People who have symptoms or complaints of coughing. - People where the appropriate consent forms have been signed — by the person themselves if aged 18 or over, by a parent or legal guardian along with the person if aged 16 or 17, or by b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06031025 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇮🇹 IT

Who might be able to join this trial: - Babies born before 31 weeks of pregnancy - Babies born before 37 weeks of pregnancy who have significant breathing or brain-related health problems - Babies who experienced a lack of oxygen around the time of birth Who may not be able to join: - Cases where a parent or guardian...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06042127 · Chinese University of Hong Kong Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 31 October 2025
🇨🇳 CN Hong Kong🇮🇳 IN🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 65 years old who have been diagnosed with symptomatic achalasia type I or II (a swallowing condition where the food pipe has difficulty moving food into the stomach) - People who are able to understand the study requirements, complete certain questionnai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06084572 · Universitair Ziekenhuis Brussel Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇧🇪 BE🇩🇪 DE

Who might be able to join this trial: - Adults between 18 and 80 years of age - People who have had a specific reflux monitoring test (called pH-MII) done while not taking acid-reducing medications known as PPIs (proton pump inhibitors) Who may not be able to join: - People whose previous camera examination of the upp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06114836 · Nationwide Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2028
🇺🇸 US

**Who might be able to join this trial:** - Babies who are currently in a neonatal intensive care unit (NICU) and are between 37 and 47 weeks of postmenstrual age (this is the baby's age calculated from the mother's last menstrual period) at the time the study begins - Babies who have been diagnosed with gastroesophage...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06129474 · University of Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
🇨🇭 CH

**Who might be able to join this trial:** - People who are a patient of a GP (general practitioner) who is taking part in the trial. - People who are at least 18 years old. - People who have been taking a PPI (a type of medication that reduces stomach acid) every day for at least 8 weeks. - People who are taking one of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06241183 · Stony Brook University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2027
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with dyspepsia (indigestion) - People who arrive at the emergency department with upper abdominal pain rated at least 3 out of 10 on a pain scale Who may not be able to join: - People who have a known aller...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06255886 · Odense University Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 26 December 2026
🇩🇰 DK

Who might be able to join this trial: - Babies who have been diagnosed with gastroesophageal reflux disease (GERD), which is a condition where stomach contents come back up into the food pipe - Babies who were referred to the trial before their first birthday - Babies who are older than 1 month at the time treatment be...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06280664 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 50 years of age - People who are able to understand and agree to participate in the study on their own - People with a Body Mass Index (a measure of body weight relative to height) below 30 - People whose hiatal defect (a gap where the stomach can push up th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06309199 · Chulalongkorn University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2026
🇹🇭 TH

Who might be able to join this trial: - Babies who were born full-term (between 37 and 41 weeks of pregnancy) - Babies whose birth weight is normal for their age - Babies who scored higher than 8 on the APGAR health check (a standard newborn assessment) at 10 minutes after birth - Babies who had a normal physical exami...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06339801 · Hospital de Clinicas José de San Martín Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇦🇷 AR

**Who might be able to join this trial:** - People over 18 years old who have symptoms of gastroesophageal reflux disease (GERD — commonly known as acid reflux or heartburn) that have not improved enough after taking acid-reducing medications called proton pump inhibitors (PPIs) for at least 8 weeks. - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06348420 · Qilu Hospital of Shandong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 60 years old - People who have a small hiatal hernia (a condition where part of the stomach slides into the chest) of 2 cm or less - People whose hernia is the "sliding" type and measures 2 cm or less - People whose acid reflux (GERD) symptoms come...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06349564 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - People aged between 21 and 65 years old - People who are having a routine screening colonoscopy, or a diagnostic camera examination of the upper digestive tract to investigate acid reflux or stomach discomfort, at NYU Langone Brooklyn Hospital Who may not be able to join: - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06488274 · United Pharmaceuticals Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇫🇷 FR

Who might be able to join this trial: - Babies who have at least one of certain common digestive problems (such as frequent spitting up, colic, or constipation), as defined by adapted Rome IV guidelines (confirm with trial site for specific definitions) - Babies who were born at 35 weeks of pregnancy or later - Babies...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06495606 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2025
🇨🇭 CH

Who might be able to join this trial: - People who are 18 years of age or older - People who are willing and able to give their consent to participate - People who are currently being assessed or tested for gastroesophageal reflux (a condition where stomach acid flows back into the food pipe) using standard medical pro...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06534359 · Children's Hospital of Philadelphia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

**Who might be able to join this trial:** - Babies who were born before 32 weeks of pregnancy - Babies who are currently between 36 and 65 weeks post-menstrual age (the age calculated from the mother's last period before pregnancy) - Babies who have been diagnosed with bronchopulmonary dysplasia (a lung condition affe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06564246 · Tanta University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 August 2026
🇪🇬 EG

**Who might be able to join this trial:** - People between the ages of 17 and 60 years old - People of any gender - People who score 8 or higher on a standard GERD symptom questionnaire (called the GERD-Q), which is used to confirm a diagnosis of acid reflux disease **Who may not be able to join:** - People who have a...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06564558 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 December 2024
🇱🇧 LB

Who might be able to join this trial: - People aged between 18 and 60 years old - People who have been diagnosed with GERD (acid reflux disease) by their doctor - People who have a spinal curvature (rounded upper back) with an angle greater than 30 degrees, as measured by a medical professional - People who score 8 or...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06613438 · Gerd Care Medical Ltd Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇮🇱 IL🇺🇸 US

Who might be able to join this trial: - People aged between 22 and 75 years old (male or female) - People who have experienced at least three episodes of heartburn and/or acid reflux per week over the past three months - People who have had a specific acid monitoring test (either a wireless "Bravo" test or a tube-based...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06617013 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - Children between 2 and 18 years old who have been diagnosed with Cystic Fibrosis (CF), confirmed either by a sweat test or by having 2 known CF-causing gene changes - A parent or guardian (and the child if old enough) must be willing to sign a consent form agreeing to take part...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06621706 · Beni-Suef University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 September 2025
🇪🇬 EG

Who might be able to join this trial: - Women who are pregnant and scheduled for a planned (non-emergency) caesarean section - Between 18 and 40 years of age - Classified as having a moderate level of health risk for surgery (a medical rating system called ASA class II or III — confirm with trial site if unsure what th...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06621979 · GCS Ramsay Santé pour l'Enseignement et la Recherche Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older - People who have had a type of weight loss surgery called a one anastomosis gastric bypass, followed by a procedure called fundoplication (a surgery to treat severe acid reflux using the excluded part of the stomach), within the 2 years before joining...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06641375 · Asian Institute of Gastroenterology, India Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2025
🇮🇳 IN

Who might be able to join this trial: - People who have had ongoing acid reflux or heartburn symptoms (at least twice a week) for the past 6 months or more - People whose reflux has been confirmed by a pH study, which is a test that measures acid levels in the oesophagus over a period of time - People who have been pre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06643325 · Kantonsspital Winterthur KSW Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇨🇭 CH

Who might be able to join this trial: - People who have experienced a traumatic injury that is relevant to the trial's focus Who may not be able to join: - People whose traumatic injury is life-threatening and requires immediate medical treatment - People who are under 18 years of age (confirm with trial site for exac...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06660342 · Phathom Pharmaceuticals, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2034
🇺🇸 US

Who might be able to join this trial: - Women between 15 and 50 years of age - People who are currently pregnant or were recently pregnant - People who agree to take part in the study - People who agree to allow their healthcare provider(s) to share their health information with the registry - For the exposed group: pe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06693622 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2029
🇺🇸 US

Who might be able to join this trial: - People who are able to sign and date a consent form. - People who are willing to follow all study procedures and are available for the whole duration of the study. - People who have 3 or more established risk factors for Barrett's Oesophagus (a condition affecting the food pipe),...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06746623 · Louis Stokes VA Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults between 41 and 84 years old who have never had an upper digestive tract camera examination (endoscopy) before and are able to give written consent to participate - People who do not have ongoing heartburn or reflux symptoms and are not taking any regular medication fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06755671 · Shanghai Hutchison Pharmaceuticals Limited Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 75 years old - People who have at least one of the following symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux, or constipation - People who are already taking a medicine called Danning Tablets as part of their regular treatment fo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06757296 · Singapore Health Services Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2026
🇸🇬 SG

**Who might be able to join this trial:** - People aged between 21 and 65 years old - People who are scheduled to have a laparoscopic sleeve gastrectomy (a type of weight-loss stomach surgery) at one of the participating hospitals - People who are able to understand and agree to take part by signing a consent form **W...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06778824 · Hualien Tzu Chi General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 18 and 75 years who are alert and able to understand and sign a consent form. - People who have long-term esophageal (food pipe) symptoms linked to how the brain and gut communicate with each other, such as heartburn, acid reflux, the feeling of something...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06783751 · University of California, Irvine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2028
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 65 years old, of any gender - People with a body mass index (BMI) between 35 and 55 (a measure of body weight relative to height) - People whose BMI falls within that range both before and after completing 6 months of non-surgical weight management a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06928350 · Asian Institute of Gastroenterology, India Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇮🇳 IN

Who might be able to join this trial: - Adults between 18 and 50 years of age - People with no stomach or digestive symptoms - People who have not had any surgery on the stomach, intestines, chest, or spine in the past - People who are not taking any medications - People who have not consumed any alcohol in the past mo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06939465 · Hualien Tzu Chi General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 24 April 2025
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 18 and 75 years who are mentally alert and willing to sign a consent form. - People who have long-lasting esophageal (food pipe) symptoms thought to be related to how the brain and gut communicate with each other — such as heartburn, acid reflux, the feeli...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06953986 · Asian Institute of Gastroenterology, India Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 November 2026
🇮🇳 IN

**Who might be able to join this trial:** - Adults aged 18 or older - People who have had reflux esophagitis (irritation and inflammation of the food pipe caused by stomach acid) confirmed by a camera examination of the stomach, graded as moderate to severe (LA grade B, C, or D) - People who have been experiencing hear...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06955520 · Asian Institute of Gastroenterology, India Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 December 2027
🇮🇳 IN

Who might be able to join this trial: - Adults aged 18 or older - People who have previously had a procedure called POEM (Per-Oral Endoscopic Myotomy) to treat a swallowing condition called achalasia - People who had a camera examination of their food pipe 3 months after POEM that showed a moderate to severe level of a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06984484 · Devintec Sagl Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇮🇹 IT

**Who might be able to join this trial:** - Adults between 18 and 75 years old (male or female) - People experiencing ongoing heartburn and/or regurgitation (with or without stomach pain or burning) that is at least mild to moderate in severity, or that has occurred during the 7 days before the start of the study, as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06991348 · Carnot Laboratories Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 November 2025
🇲🇽 MX

Who might be able to join this trial: - People who have been diagnosed with acid reflux disease (GERD) or a related condition (NERD) through a camera examination of the stomach, done within the last 15 days. - People who have had a specific test measuring acid and fluid movement in the food pipe (called impedance pHmet...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06999577 · University of California, San Diego Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 May 2029
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 to 89 years old - People who have had throat or voice symptoms — such as coughing, frequent throat clearing, or a hoarse or changed voice — lasting more than 8 weeks - People who are scheduled to undergo a standard camera examination of the throat and food pipe...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07037875 · Cinclus Pharma Holding AB Phase 3 · 7 countries Recruiting
Recruiting Phase 3 Est. completion 1 August 2026
🇧🇬 BG🇨🇿 CZ🇬🇪 GE🇩🇪 DE🇭🇺 HU🇵🇱 PL🇷🇴 RO

**Who might be able to join this trial:** - People who are willing to read and sign a consent form before any study activities begin. - People aged 18 to 80 years old at the time of signing the consent form. - People who are able and willing to follow all parts of the study, including attending camera examinations of...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07057466 · Imperial College London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 3 May 2027
🇬🇧 GB

Who might be able to join this trial: - You are between 18 and 90 years old - You have never been officially diagnosed with heart failure (including any type of reduced or preserved heart pumping function), high blood pressure in the lungs (pulmonary hypertension), or a heart valve disease - You are able to understand...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07063576 · Adnan Imtiaj Rahul Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 July 2026
Bangladesh

**Who might be able to join this trial:** - People aged 18 or older - People who still have ongoing heartburn and/or regurgitation symptoms despite taking a standard acid-reducing medication (called a PPI) for at least 8 weeks **Who may not be able to join:** - People whose heartburn or reflux symptoms come with warni...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07093359 · University of Oxford Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 February 2029
🇬🇧 GB

Who might be able to join this trial: - People aged 18 years or older - People who are willing and able to give informed consent to participate - People with gastro-oesophageal reflux disease (acid reflux) that is not well controlled by medication, or who cannot tolerate the medication, and who are being considered for...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07099417 · I.M. Sechenov First Moscow State Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇷🇺 RU

**Who might be able to join this trial:** - People aged 18 years or older - People who have given written agreement to take part in the study - People who are being seen as outpatients or are admitted to a participating research centre **Who may not be able to join:** - People who do not wish to take part in the study...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07121803 · Federal State Budgetary Scientific Institution Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2025
🇷🇺 RU

**Who might be able to join this trial:** - People who are willing to take part and have signed a written consent form - People whose blood sugar levels are stable and well-controlled - People whose diabetes treatment (such as metformin, certain tablets, or insulin) has not changed — including no new medications added...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07125521 · Institute of Gastroenterology and Hepatology, Vietnam Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇻🇳 VN

Who might be able to join this trial: - People who are 18 years of age or older - People who experience typical acid reflux symptoms, such as heartburn or regurgitation (the sensation of stomach contents coming back up) - People who own a smartphone and are able to use apps on it Who may not be able to join: - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07131397 · University of West Attica Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2027
🇬🇷 GR

**Who might be able to join this trial:** - People who have been diagnosed with gastroesophageal reflux disease (GERD), which is a condition where stomach acid regularly flows back into the food pipe, causing discomfort - People who scored more than 8 on a specific questionnaire used to measure reflux symptoms (called...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07148492 · Khyber Teaching Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2025
🇵🇰 PK

"Who might be able to join this trial: - People who are scheduled to have a type of weight loss surgery called a one anastomosis gastric bypass Who may not be able to join: - People who have not given their consent to participate in the trial Important: Always verify eligibility with the trial site directly before ap...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07148583 · Haiphong University of Medicine and Pharmacy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2026
🇻🇳 VN

**Who might be able to join this trial:** - Infants aged 0 to 24 months old at the time of joining the trial - Infants who have been assessed by a clinician as having functional gut symptoms, such as colic, irritability, spitting up, constipation, or loose stools, and who a clinician considers suitable for the study -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07158008 · Jagiellonian University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2028
🇵🇱 PL

**Who might be able to join this trial:** *For the N-Sleeve Gastrectomy or Gastric Bypass groups:* - People who are 18 years of age or older - People who are willing and able to provide written consent to participate - People whose body weight meets national guidelines for weight-loss surgery — specifically, a BMI of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07227506 · Medical College of Wisconsin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

Who might be able to join this trial: - People who have ongoing esophageal (food pipe) symptoms — such as heartburn, acid reflux, or difficulty swallowing — and are already scheduled to have an upper endoscopy (a camera test of the food pipe and stomach). Who may not be able to join: - People who have a narrowing or b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07252115 · Beijing Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇨🇳 CN

Who might be able to join this trial: - People between 18 and 85 years of age. - People who have been diagnosed with a hiatal hernia (a condition where part of the stomach pushes up through the diaphragm into the chest), including any type from mild to severe. - People whose acid reflux (heartburn) symptoms have not im...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07267117 · Second Affiliated Hospital, School of Medicine, Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

Who might be able to join this trial: - People who are at least 18 years old - People who are willing and able to give their consent to take part in the study - People who have been diagnosed with heart valve disease through an ultrasound of the heart (echocardiography), and whose results meet specific measurements sho...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07268820 · Incheon St.Mary's Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 29 May 2026
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 19 years or older who are Korean residents, as of the date of signing consent - People who have been diagnosed with erosive gastroesophageal reflux disease (a condition where stomach acid damages the lining of the food pipe) confirmed by a camera examination of th...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07291700 · Bayer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇩🇪 DE

**Who might be able to join this trial:** - Adults aged 18 or older (male or female) - People who have stopped taking a proton pump inhibitor (a type of stomach acid-reducing medication) after using it daily for at least 8 weeks, where that medication was no longer considered necessary based on current medical guideli...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07449728 · Pirogov Russian National Research Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 January 2028
🇷🇺 RU

Who might be able to join this trial: - People who are older than 18 years of age - People who have varicose veins that have been classified by doctors as falling within a specific range of severity (known as CEAP clinical class C2 to C6, which covers visible varicose veins through to active leg ulcers — confirm with t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07482969 · University Hospital, Motol Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2028
🇨🇿 CZ

Who might be able to join this trial: - Children who are 8–9 years old or 12–13 years old - Children who are able to attend school Who may not be able to join: - Children who have a condition affecting both their physical movement and mental processing abilities (sometimes called psychomotor impairment) Important: Al...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07506356 · University Hospital, Geneva Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇭 CH

Who might be able to join this trial: - Adults aged 18 or older - People who have been diagnosed with Type 2 Diabetes - People who have been taking a GLP-1 analog medication for more than 3 months - People who have signed a consent form agreeing to take part - People with an ASA physical status classification between I...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07506746 · IRCCS San Raffaele Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2031
🇮🇹 IT

Who might be able to join this trial: - People who are willing and able to give their informed consent to take part in the study - People whose procedures are already part of their standard medical care, or who are already taking the relevant medication as part of their normal clinical treatment - People aged 18 years...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07544433 · Changhua Christian Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2028
🇹🇼 TW

**Who might be able to join this trial:** - People aged between 20 and 80 years old. - People with a confirmed diagnosis of gastroesophageal reflux disease (GERD — a condition where stomach acid regularly flows back into the food pipe), confirmed by at least one of the following: - An internal camera examination (endo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07556289 · Chinese University of Hong Kong Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2026
Hong Kong

Who might be able to join this trial: - People between 18 and 80 years of age - People who have had acid reflux (GERD) symptoms, including troublesome regurgitation (stomach contents coming back up), for more than 6 months, even while taking at least 40 mg of acid-reducing medication (called a PPI) daily - People whose...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07600008 · University Hospital Olomouc Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 30 May 2026
🇨🇿 CZ

**Who might be able to join this trial:** - People who have been diagnosed with GERD (gastroesophageal reflux disease, also known as chronic acid reflux) - People who are in generally stable health with no current serious complications - People who are currently taking a stable, regular dose of a acid-reducing medicati...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT07624383 · Cellmedis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇵🇱 PL

**Who might be able to join this trial:** - People who have been diagnosed with gastroesophageal reflux disease (acid reflux), with typical symptoms such as heartburn and/or regurgitation lasting at least 6 months before the screening visit, as confirmed by the investigator - People who have had a camera test of the u...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07635836 · Qilu Hospital of Shandong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇳 CN

Who might be able to join this trial: - People who have been confirmed through a biopsy to have a specific type of stomach cancer called gastric adenocarcinoma - People whose cancer is located in the upper part of the stomach, or at the junction where the food pipe meets the stomach (a specific category called Siewert...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07678177 · HK inno.N Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇰🇷 KR

Who might be able to join this trial: - People who are 20 years of age or older at the time of signing the consent form (confirm with trial site) - People whose symptoms of acid reflux or heartburn score 8 or higher on a specific questionnaire called the GerdQ, assessed at the first visit - People who choose to take pa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07700342 · Cellmedis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇵🇱 PL

**Who might be able to join this trial:** - People who have been diagnosed with gastroesophageal reflux disease (acid reflux), with typical symptoms such as heartburn and/or regurgitation lasting at least 6 months before the screening visit, as confirmed by the trial doctor. - People who have had a stomach camera test...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07708220 · Tanta University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇪🇬 EG

Who might be able to join this trial: - Children who have been diagnosed with gastroesophageal reflux disease (GERD), also known as chronic acid reflux, and are between 2 years old and 18 years old Who may not be able to join: - Children who have previously had surgery to treat acid reflux or related conditions - Chil...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07718828 · Sofia Med Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇧🇬 BG

Who might be able to join this trial: - People between 18 and 90 years of age - People who have been diagnosed with a hiatal hernia (where part of the stomach pushes up through the diaphragm) for the first time, confirmed by a camera examination of the stomach and/or an X-ray swallow test - People who are experiencing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07726173 · Johns Hopkins University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 21 years of age or older - People who have been diagnosed with severe degenerative mitral regurgitation (a serious heart valve problem where the mitral valve leaks significantly), confirmed by an ultrasound of the heart - People whose mitral valve leaflets (the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.